GABA signaling enforces intestinal germinal center B cell differentiation

Proc Natl Acad Sci U S A. 2022 Nov;119(44):e2215921119. doi: 10.1073/pnas.2215921119. Epub 2022 Oct 24.

Abstract

Recent compelling results indicate possible links between neurotransmitters, intestinal mucosal IgA+ B cell responses, and immunoglobulin A nephropathy (IgAN) pathogenesis. Here, we demonstrated that γ-amino butyric acid (GABA) transporter-2 (GAT-2) deficiency induces intestinal germinal center (GC) B cell differentiation and worsens the symptoms of IgAN in a mouse model. Mechanistically, GAT-2 deficiency enhances GC B cell differentiation through activation of GABA-mammalian target of rapamycin complex 1 (mTORC1) signaling. In addition, IgAN patients have lower GAT-2 expression but higher activation of mTORC1 in blood B cells, and both are correlated with kidney function in IgAN patients. Collectively, this study describes GABA signaling-mediated intestinal mucosal immunity as a previously unstudied pathogenesis mechanism of IgAN and challenges the current paradigms of IgAN.

Keywords: B cells; GABA; IgA; IgAN; germinal center.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Germinal Center / metabolism
  • Glomerulonephritis, IGA*
  • Immunoglobulin A / metabolism
  • Mammals
  • Mechanistic Target of Rapamycin Complex 1 / metabolism
  • Mice
  • TOR Serine-Threonine Kinases / metabolism
  • gamma-Aminobutyric Acid / metabolism

Substances

  • gamma-Aminobutyric Acid
  • Immunoglobulin A
  • TOR Serine-Threonine Kinases
  • Mechanistic Target of Rapamycin Complex 1